Quick Answer
PharmaCyte Biotech, Inc. reported Shares Outstanding of 6.80 million shares for fiscal year 2025.
PharmaCyte Biotech, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 6.80M | -15.5% |
| 2024 | 8.04M | -52.1% |
| 2023 | 16.79M | -19.0% |
| 2022 | 20.72M | +1203.1% |
| 2021 | 1.59M | +45.6% |
| 2020 | 1.09M | -99.9% |
| 2019 | 1.19B | +17.0% |
| 2018 | 1.01B | +11.9% |
| 2017 | 905.35M | +15.9% |
| 2016 | 781.23M | +6.6% |
| 2015 | 732.76M | +6.1% |
| 2014 | 690.62M | +43.2% |
| 2013 | 482.11M | +15.8% |
| 2012 | 416.29M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | 10.74M | +55.5% | +58.0% |
| July 31, 2025 | 6.80M | -11.9% | +0.0% |
| April 30, 2025 | 6.80M | -15.5% | -1.6% |
| January 31, 2025 | 6.90M | -19.0% | -1.8% |
| October 31, 2024 | 7.03M | -19.1% | -8.9% |
| July 31, 2024 | 7.72M | -12.1% | -4.0% |
| April 30, 2024 | 8.04M | -52.1% | -5.7% |
| January 31, 2024 | 8.52M | -53.2% | -2.1% |
- PharmaCyte Biotech, Inc. showed a decrease of -15.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, PharmaCyte Biotech, Inc.’s shares outstanding has declined by 98.4% (from 416.29 million shares to 6.80 million shares).
- The most recent figure is from PharmaCyte Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 11, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: